NYSEMKT:IMUC Investor Alert: Lawsuit Alleges Misleading Statements by ImmunoCellular Therapeutics Ltd
An investor in NYSEMKT:IMUC shares filed a lawsuit against ImmunoCellular Therapeutics over alleged Securities Laws violations.
View full press release